Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Effects of Weight-Loss Medications on Cardiometabolic Risk Profiles: A Systematic Review and Network Meta-analysis.

Khera R, Pandey A, Chandar AK, Murad MH, Prokop LJ, Neeland IJ, Berry JD, Camilleri M, Singh S.

Gastroenterology. 2018 Apr;154(5):1309-1319.e7. doi: 10.1053/j.gastro.2017.12.024. Epub 2018 Jan 3. Review.

PMID:
29305933
2.

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis.

Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, Loomba R, Camilleri M, Singh S.

JAMA. 2016 Jun 14;315(22):2424-34. doi: 10.1001/jama.2016.7602. Review. Erratum in: JAMA. 2016 Sep 6;316(9):995.

3.

Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis.

Peirson L, Douketis J, Ciliska D, Fitzpatrick-Lewis D, Ali MU, Raina P.

CMAJ Open. 2014 Oct 1;2(4):E306-17. doi: 10.9778/cmajo.20140012. eCollection 2014 Oct.

4.

Long-term drug treatment for obesity: a systematic and clinical review.

Yanovski SZ, Yanovski JA.

JAMA. 2014 Jan 1;311(1):74-86. doi: 10.1001/jama.2013.281361. Review.

5.
6.

Effect of anti-obesity drug on cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials.

Zhou YH, Ma XQ, Wu C, Lu J, Zhang SS, Guo J, Wu SQ, Ye XF, Xu JF, He J.

PLoS One. 2012;7(6):e39062. doi: 10.1371/journal.pone.0039062. Epub 2012 Jun 20. Review.

7.

Evaluation of efficacy and safety of orlistat in obese patients.

Jain SS, Ramanand SJ, Ramanand JB, Akat PB, Patwardhan MH, Joshi SR.

Indian J Endocrinol Metab. 2011 Apr;15(2):99-104. doi: 10.4103/2230-8210.81938.

8.

Tackling obesity: new therapeutic agents for assisted weight loss.

Karam J, McFarlane S.

Diabetes Metab Syndr Obes. 2010 Apr 26;3:95-112.

9.

Impact of orlistat-induced weight loss on diastolic function and heart rate variability in severely obese subjects with diabetes.

Martin J, Paquette C, Marceau S, Hould FS, Lebel S, Simard S, Dumesnil JG, Poirier P.

J Obes. 2011;2011:394658. doi: 10.1155/2011/394658. Epub 2010 Dec 23.

10.

Attrition from randomized controlled trials of pharmacological weight loss agents: a systematic review and analysis.

Fabricatore AN, Wadden TA, Moore RH, Butryn ML, Gravallese EA, Erondu NE, Heymsfield SB, Nguyen AM.

Obes Rev. 2009 May;10(3):333-41. doi: 10.1111/j.1467-789X.2009.00567.x. Epub 2009 Mar 6. Review.

11.

Industry funding and the reporting quality of large long-term weight loss trials.

Thomas O, Thabane L, Douketis J, Chu R, Westfall AO, Allison DB.

Int J Obes (Lond). 2008 Oct;32(10):1531-6. doi: 10.1038/ijo.2008.137. Epub 2008 Aug 19. Review.

12.

Obesity management: update on orlistat.

Drew BS, Dixon AF, Dixon JB.

Vasc Health Risk Manag. 2007;3(6):817-21. Review.

13.

Efficacy of orlistat as an adjunct to behavioral treatment in overweight African American and Caucasian adolescents with obesity-related co-morbid conditions.

McDuffie JR, Calis KA, Uwaifo GI, Sebring NG, Fallon EM, Frazer TE, Van Hubbard S, Yanovski JA.

J Pediatr Endocrinol Metab. 2004 Mar;17(3):307-19.

14.

Extracts from "Clinical Evidence". Obesity.

Arterburn D, Noël PH.

BMJ. 2001 Jun 9;322(7299):1406-9. No abstract available.

Supplemental Content

Support Center